Scholarship

Postgraduate Research Scholarship to Develop Novel Vectors Based on AAV

University of Sydney Original Source
Award

A$140,000 - A$140,000

Deadline

Dec 15, 2021

Deadline passed
Location

Australia

Applicants

individual

About This Opportunity

This scholarship provides funding for a PhD student within the Faculty of Medicine and Health at the University of Sydney to conduct research in developing novel vectors based on adeno-associated virus (AAV). The research focuses on enhancing cardiac gene delivery and overcoming the translational barrier of this technology in its use for inherited and acquired heart disease. This scholarship is funded by NSW Health and the University of Sydney as part of the NSW Health Gene and Cell Therapy PhD Program. The successful recipient will receive a stipend allowance and is expected to attend the Commercialisation Training Program and Program Evaluation of the NSW Health Cell and Cell Therapy PhD Program.

Duration 36 - 43 mo
1 award

Who Can Apply

Region
Australia
Citizenship
Australia
Residency
Australia
Project in
Australia
Applicants
individual
Organizations
academic

Application Details

Interview Institutional approval

Stages

  1. 1 two_stage

Required documents

cv cover_letter transcripts letters_of_recommendation

Review process

Applications reviewed based on academic merit, cover letter, academic referee reports, and curriculum vitae. Shortlisted applicants required to attend interview. Selection by committee from Faculty of Medicine and Health.

Additional benefits

  • training

Restrictions

  • no_concurrent_funding
  • reporting_requirements

Post-award obligations

  • final_report
  • acknowledge_funder
  • present_findings